Suzuki, Yoshiyuki

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Llovet, J. M., Kudo, M., Merle, P., Meyer, T., Qin, S., Ikeda, M., Xu, R., Edeline, J., Ryoo, B.-Y., Ren, Z., et al. (2023) · The Lancet Oncology

Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies

Cited by 469

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma

Kawamura, Y., Arase, Y., Ikeda, K., Seko, Y., Imai, N., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., et al. (2012) · American Journal of Gastroenterology

Liver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and Prognosis

Cited by 280

Comprehensive analysis of endogenous bornavirus-like elements in eukaryote genomes

Horie, M., Kobayashi, Y., Suzuki, Y., & Tomonaga, K. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences

Chromosomal and Genetic VariationsVirology and Viral Diseases

Cited by 85

SGLT2 inhibitor treatment outcome in nonalcoholic fatty liver disease complicated with diabetes mellitus: the long-term effects on clinical features and liver histopathology

Akuta, N., Kawamura, Y., Fujiyama, S., Sezaki, H., Hosaka, T., Kobayashi, M., Kobayashi, M., Saitoh, S., Suzuki, F., Suzuki, Y., et al. (2020) · Internal Medicine

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 48

Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome

SUZUKI, Y., ARASE, Y., IKEDA, K., SAITOH, S., TSUBOTA, A., SUZUKI, F., KOBAYASHI, M., AKUTA, N., SOMEYA, T., MIYAKAWA, Y., et al. (2004) · Journal of Gastroenterology and Hepatology

Liver Diseases and ImmunityIgG4-Related and Inflammatory Diseases

Cited by 40